Clinical trial

D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer

NCT03861156

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-02-28

PhasePHASE2

Study timeline

Study start (actual)2019-02-28Date precision: day

Registry last updated2024-04-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Solid Tumorunresolved

NSCLCunresolved

EGFR T790Munresolved

Interventions

D-0316DRUG

Sponsors & collaborators

InventisBio Co., Ltdlead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03861156 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.